Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Thromb Haemost 2012; 107(06): 1189-1191
DOI: 10.1160/TH11-11-0788

Letters to the Editor

Schattauer GmbH

Dabigatran etexilate (Pradaxa^®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Cedric Hermans

¹Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

,

Stéphane Eeckhoudt

²Hemostasis and Thrombosis Laboratory, Division of Biological Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium

,

Catherine Lambert

¹Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

References
1 Ward CT, Chavalitanonda N. Atypical warfarin-induced skin necrosis. Pharmacotherapy 2006; 26: 1175-1179.
2 AdEl DD, Meirovitz A, Weinberg A. et al. Warfarin skin necrosis: local and systemic factors. Br J Plast Surg 2000; 53: 624-626.
3 Nazarian RM, Van Cott EM, Zembowicz A. et al. Warfarin-induced skin necrosis. J Am Acad Dermatol 2009; 61: 325-332.
4 Gelwix TJ, Beeson MS. Warfarin-induced skin necrosis. Am J Emerg Med 1998; 16: 541-543.
5 Stewart AJ, Penman ID, Cook MK. et al. Warfarin-induced skin necrosis. Postgrad Med J 1999; 75: 233-235.
6 Essex DW, Wynn SS, Jin DK. Late-onset warfarin-induced skin necrosis: case report and review of the literature. Am J Hematol 1998; 57: 233-237.
7 Cole MS, Minifee PK, Wolma FJ. Coumarin necrosis--a review of the literature. Surgery 1988; 103: 271-277.
8 Sorensen DM, Eilbert W. Images in emergency medicine. Man with painful skin lesion. Warfarin sodium skin necrosis. Ann Emerg Med 2010; 55: 302-305.
9 Perzborn E, Roehrig S, Straub A. et al. The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. Nat Rev Drug Discov 2011; 10: 61-75.
10 Hankey GJ, Eikelboom JW. Dabigatran etexilate: a new oral thrombin inhibitor. Circulation 2011; 123: 1436-1450.